Author

Mark T. Albrecht

Observed names: M. T. Albrecht, Mark Albrecht, Mark T Albrecht

Institution: Biomedical Advanced Research and Development Authority

Observed institutions: University of California, Riverside, United States Department of Health and Human Services, Naval Medical Research Command, Biomedical Advanced Research and Development Authority, Ichor Medical Systems (United States), Administration for Strategic Preparedness and Response, The Ohio State University, University of California, Berkeley

ORCID: 0009-0001-9708-5279

Observed ORCID: 0009-0001-9708-5279

OpenAlex ID: A5072736847

In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants

2010 · Eric M. Bachelder, Tristan T. Beaudette, et al. · Molecular Pharmaceutics · 137

Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax

2007 · Mark T. Albrecht, Han Li, et al. · Infection and Immunity · 106

Alginate Lyase (AlgL) Activity Is Required for Alginate Biosynthesis in Pseudomonas aeruginosa

2005 · Mark T. Albrecht, Neal L. Schiller · Journal of Bacteriology · 63

Ultra-fast pg/ml anthrax toxin (protective antigen) detection assay based on microwave-accelerated metal-enhanced fluorescence

2012 · Anatoliy I. Dragan, Mark T. Albrecht, et al. · Analytical Biochemistry · 37

Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia

2002 · Mark T Albrecht, Wei Wang, et al. · Respiratory Research · 34

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

2014 · Rona Hirschberg, Lucy Ward, et al. · Viruses · 30

A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates fromB. anthracisspore challenge

2011 · Vadim Mett, Jessica A. Chichester, et al. · Human Vaccines · 30

Animal Models for Francisella tularensis and Burkholderia Species: Scientific and Regulatory Gaps Toward Approval of Antibiotics Under the FDA Animal Rule

2013 · M. V. Stundick, M. T. Albrecht, et al. · Veterinary Pathology · 26

Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose

2022 · Andrew J. Phipps, Julie N. Bergmann, et al. · Antimicrobial Agents and Chemotherapy · 21

Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague

2012 · Mark T. Albrecht, Brian D. Livingston, et al. · Vaccine · 20

Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model

2012 · Mark T. Albrecht, Jim E. Eyles, et al. · FEMS Immunology & Medical Microbiology · 15

DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System

2014 · Andrea M. Keane-Myers, Matt Bell, et al. · Methods in molecular biology · 8

Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority

2022 · Julie N. Bergmann, Rushyannah R. Killen-Cade, et al. · Human Vaccines & Immunotherapeutics · 5

Modeling the Impact of Antimicrobial Resistance on Medical Preparedness and Response for a Nuclear or Radiological Public Health Emergency

2025 · Andrew J. Phipps, Sue K. Cammarata, et al. · Disaster Medicine and Public Health Preparedness · 1

Recommendations to Improve Collaboration and Expedite Acceptance of Animal Models

2013 · M. V. Stundick, M. T. Albrecht, et al. · Veterinary Pathology

Works count: 16

Citation count: 533

H-index: 11

I10-index: 11